Federal Register / Vol. 65, No. 218 / Thursday, November 9, 2000 / Notices 67403

by the Secretary for those parties

authorized to receive BPI under the

APO.

Staff Report

The prehearing staff report in the final

phase of these investigations will be

placed in the nonpublic record on

February 6, 2001, and a public version

will be issued thereafter, pursuant to

section 207.22 of the Commission’s

rules.

Hearing

The Commission will hold a hearing

in connection with the final phase of

these investigations beginning at 9:30

a.m. on February 21, 2001, at the U.S.

International Trade Commission

Building. Requests to appear at the

hearing should be filed in writing with

the Secretary to the Commission on or

before February 14, 2001. A nonparty

who has testimony that may aid the

Commission’s deliberations may request

permission to present a short statement

at the hearing. All parties and

nonparties desiring to appear at the

hearing and make oral presentations

should attend a prehearing conference

to be held at 9:30 a.m. on February 16,

2001, at the U.S. International Trade

Commission Building. Oral testimony

and written materials to be submitted at

the public hearing are governed by

sections 201.6(b)(2), 201.13(f), and

207.24 of the Commission’s rules.

Parties must submit any request to

present a portion of their hearing

testimony in camera no later than 7

days prior to the date of the hearing.

Written Submissions

Each party who is an interested party

shall submit a prehearing brief to the

Commission. Prehearing briefs must

conform with the provisions of section

207.23 of the Commission’s rules; the

deadline for filing is February 13, 2001.

Parties may also file written testimony

in connection with their presentation at

the hearing, as provided in section

207.24 of the Commission’s rules, and

posthearing briefs, which must conform

with the provisions of section 207.25 of

the Commission’s rules. The deadline

for filing posthearing briefs is February

28, 2001; witness testimony must be

filed no later than three days before the

hearing. In addition, any person who

has not entered an appearance as a party

to the investigations may submit a

written statement of information

pertinent to the subject of the

investigations on or before February 28,

2001. On March 15, 2001, the

Commission will make available to

parties all information on which they

have not had an opportunity to

comment. Parties may submit final

comments on this information on or

before March 19, 2001, but such final

comments must not contain new factual

information and must otherwise comply

with section 207.30 of the Commission’s

rules. All written submissions must

conform with the provisions of section

201.8 of the Commission’s rules; any

submissions that contain BPI must also

conform with the requirements of

sections 201.6, 207.3, and 207.7 of the

Commission’s rules. The Commission’s

rules do not authorize filing of

submissions with the Secretary by

facsimile or electronic means.

In accordance with sections 201.16(c)

and 207.3 of the Commission’s rules,

each document filed by a party to the

investigations must be served on all

other parties to the investigations (as

identified by either the public or BPI

service list), and a certificate of service

must be timely filed. The Secretary will

not accept a document for filing without

a certificate of service.

Authority: These investigations are being

conducted under authority of title VII of the

Tariff Act of 1930; this notice is published

pursuant to section 207.21 of the

Commission’s rules.

By order of the Commission.

Issued: November 3, 2000.

Donna R. Koehnke,

Secretary.

[FR Doc. 00–28729 Filed 11–8–00; 8:45 am]

BILLING CODE 7020–02–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Withdrawal

As set fourth in the Federal Register

(FR Doc. 99–26605) Vol. 64, No. 197 at

page 55489, dated October 13, 1999,

Fort Dodge Laboratories, Inc., 141 E.

Riverside Drive, Fort Dodge, Iowa

50501, made application to the Drug

Enforcement Administration to be

registered as an importer of

pentobarbital (2270).

One registered bulk manufacturer of

pentobarbital requested a hearing to

deny the proposed registration of Fort

Dodge Laboratories, Inc. Fort Dodge

Laboratories, Inc. requested by letter

that its application be withdrawn.

Therefore, Fort Dodge Laboratories,

Inc.’s, application to import

pentobarbital is hereby withdrawn.

Dated: October 30, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–28696 Filed 11–8–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Registration

By Notice dated August 22, 2000, and

published in the Federal Register on

September 6, 2000, (65 FR 54067), ISP

Freetown Fine Chemicals, Inc., 238

South Main Street, Assonet,

Massachusetts 02702, made application

to the Drug Enforcement Administration

(DEA) to be registered as an importer of

phenylacetone (8501), a basic class of

controlled substance listed in Schedule

II.

The firm plans to import the

phenylacetone to manufacture

amphetamine.

No comments or objections have been

received. DEA has considered the

factors in Title 21, United States Code,

Section 823(a) and determined that the

registration of IPS Freetown Fine

Chemicals, Inc., is consistent with the

public interest and with United States

obligations under international treaties,

conventions, or protocols in effect on

May 1, 1971, at this time. DEA has

investigated ISP Freetown Fine

Chemicals, Inc. to ensure that the

company’s registration is consistent

with the public interest. This

investigation included inspection and

testing of the company’s physical

security systems, verification of the

company’s compliance with state and

local laws, and a review of the

company’s background and history.

Therefore, pursuant to Section 1008(a)

of the Controlled Substances Import and

Export Act and in accordance with Title

21, Code of Federal Regulations,

§ 1301.34, the above firm is granted

registration as an importer of the basic

class of controlled substance listed

above.

Dated: October 18, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–28697 Filed 11–8–00; 8:45 am]

BILLING CODE 4410–09–M